Breast cancer and amyloid bodies: is there a role for amyloidosis in cancer-cell dormancy?
Open Access
- 1 April 2017
- journal article
- editorial
- Published by Taylor & Francis in Breast Cancer: Targets and Therapy
- Vol. ume 9, 287-291
Abstract
Breast cancer and Alzheimer’s disease (AD) are major causes of death in older women. Interestingly, breast cancer occurs less frequently in AD patients than in the general population. Amyloidosis, the aggregation of amyloid proteins to form amyloid bodies, plays a central role in the pathogenesis of AD and other human neuropathies by forming intracellular fibrillary proteins. Contrary to popular belief, amyloidosis is a common occurrence in mammalian cells, and has recently been reported to be a natural physiological process in response to environmental stress stimulations (such as pH and temperature extremes, hypoxia, and oxidative stress). Many proteins contain an intrinsic “amyloid-converting motif”, which acts in conjunction with a specific noncoding RNA to induce formation of proteinaceous amyloid bodies that are stored in intracellular bundles. In cancer cells such as breast and prostate, the process of amyloidosis induces cells to enter a dormant or resting stage devoid of cell division and proliferation. Therefore, cancer cells undergo growth cessation and enter a dormant stage following amyloidosis in the cell; this is akin to giving the cell AD to cease growth.Keywords
This publication has 41 references indexed in Scilit:
- Hypoxia-Inducible Factors in Physiology and MedicineCell, 2012
- The Unfolded Protein Response: From Stress Pathway to Homeostatic RegulationScience, 2011
- Light chain (AL) amyloidosis: update on diagnosis and managementJournal of Hematology & Oncology, 2011
- Bioluminescence imaging reveals inhibition of tumor cell proliferation by Alzheimer's amyloid β proteinCancer Cell International, 2009
- Update of Alpha Fetoprotein Growth-Inhibitory Peptides as Biotherapeutic Agents for Tumor Growth and MetastasisChemotherapy, 2006
- Amyloid-β Peptide Disruption of Lipid Membranes and the Effect of Metal IonsJournal of Molecular Biology, 2006
- Ab initio model studies of copper binding to peptides containing a His–His sequence: relevance to the β-amyloid peptide of Alzheimer’s diseaseJBIC Journal of Biological Inorganic Chemistry, 2005
- Amphoterin Includes a Sequence Motif Which Is Homologous to the Alzheimer's β-Amyloid Peptide (Aβ), Forms Amyloid Fibrils in Vitro, and Binds Avidly to AβBiochemistry, 2001
- Impairment of Basal Forebrain Cholinergic Neurons Associated with Aging and Long-Term Loss of Ovarian FunctionExperimental Neurology, 1998
- Alzheimer's β‐amyloid peptide: affinity for metal chelatesChemical Biology & Drug Design, 1998